Aytu Biopharma (AYTU) Total Debt (2015 - 2026)
Aytu Biopharma's Total Debt came in at $15.18 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 24.0% from $19.96 million a year earlier and down 24.0% from the prior quarter.
Aytu Biopharma (AYTU) Total Debt (2015 - 2026) Analysis & Trends
Going back to fiscal Q2 2016, Aytu Biopharma's Total Debt data covers 29 quarters.
- Total Debt carries a five-year compound annual growth rate of -2.1% (FY2021 to FY2026).
- Going back by fiscal year, Total Debt was $19.96 million in FY2025 (+27.4%), $15.67 million in FY2024 (-4.2%), $16.36 million in FY2023 (-10.0%) and $18.19 million in FY2022 (+8.0%).
- The fiscal Q4 2026 figure represents the lowest quarterly Total Debt since fiscal Q2 2021.
- Year-over-year, Total Debt increased in six of the last eight quarters, with growth averaging 12.2%.
- The fastest year-over-year change in Total Debt over five years came in fiscal Q1 2026 (growth of 52.9%), and the weakest in fiscal Q3 2024 (a decline of 33.4%).
- Business Quant data shows AYTU's Total Debt at $19.96 million (Q3 2026), $19.07 million (Q2 2026) and $25.32 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | 15.18 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.18 Mn |
| Mar 31, 2026 | 19.96 Mn |
| Dec 31, 2025 | 19.07 Mn |
| Sep 30, 2025 | 25.32 Mn |
| Jun 30, 2025 | 19.96 Mn |
| Mar 31, 2025 | 19.56 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Sep 30, 2024 | 16.56 Mn |
| Jun 30, 2024 | 15.67 Mn |
| Mar 31, 2024 | 16.72 Mn |
| Dec 31, 2023 | 16.04 Mn |
| Sep 30, 2023 | 16.12 Mn |
| Jun 30, 2023 | 16.36 Mn |
| Mar 31, 2023 | 25.09 Mn |
| Dec 31, 2022 | 22.05 Mn |
| Sep 30, 2022 | 21.65 Mn |
| Jun 30, 2022 | 18.19 Mn |
| Mar 31, 2022 | 17.55 Mn |
| Dec 31, 2021 | 16.47 Mn |
| Sep 30, 2021 | 16.66 Mn |
Aytu Biopharma Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=AYTU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();